You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Famotidine tablets fed study

Showing 1 - 25 of 5,573
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Dallas (AMG 510, Omeprazole, Famotidine)

Completed
  • Healthy Participants
  • AMG 510
  • +2 more
  • Dallas, Texas
    Covance Clinical Research Unit, Inc
Oct 26, 2022

Healthy Trial in Beijing (First Test Concor (Fasted), First Reference Concor (Fasted), First Test Concor (Fed))

Recruiting
  • Healthy
  • First Test Concor (Fasted)
  • +3 more
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University-Drug Cli
Jun 26, 2023

Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
  • Galvumet® Film Coated Tablets (850 mg / 50 mg)
  • Bab Souika, Tunise, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023

Famotidine in Covid-19 Intensive Care Unit

Completed
  • COVID-19 Pandemic
  • Famotidine Tablets
  • İ̇stanbul, Turkey
    Istanbul Medeniyet University
Apr 12, 2022

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Healthy Trial in Qingdao (test apixaban tablets, reference apixaban tablets)

Completed
  • Healthy
  • test apixaban tablets
  • reference apixaban tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
May 1, 2023

Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

Recruiting
  • Mantle Cell Lymphoma
  • LP-168 tablet
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jun 24, 2023

Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
  • Tunis, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023

MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets)

Active, not recruiting
  • Major Depressive Disorder (MDD)
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Oct 24, 2022

Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene

Recruiting
  • Bioequivalence Study
  • Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
  • Calcium Hydroxybenzene Sulfonate Tablets（Doxium®) 250mg
  • Beijing, Beijing, China
    National Institue for Drug Clinical Trials
Mar 21, 2023

Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet

Not yet recruiting
  • Healthy Volunteer
  • Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
  • Lumacaftor 200 mg Film-Coated Tablet Formulation
  • (no location specified)
Jul 21, 2023

Pharmacokinetics, Safety Trial in Qingdao (Reference preparation-Reference preparation-Test Preparation, Reference

Enrolling by invitation
  • Pharmacokinetics
  • Safety
  • Reference preparation-Reference preparation-Test Preparation
  • +2 more
  • Qingdao, Shandong, China
    Phase I clinical research center
Jul 28, 2022

Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

Active, not recruiting
  • Hypertension
  • Coronary Artery Disease
  • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
  • Norvasc 5 mg tablets of Pfizer Labs
  • Vadodara, Gujarat, India
    Accutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023

Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)

Completed
  • Bioequivalence
  • Type 2 Diabetes
  • Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

Pharmacokinetics Trial in Québec (DFD-29 (Minocycline) Fasting, DFD-29 (Minocycline) Fed, Solodyn (Minocycline) Fasting)

Active, not recruiting
  • Pharmacokinetics
  • DFD-29 (Minocycline) Fasting
  • +2 more
  • Québec, Canada
    CRO
Jul 7, 2022

Irbesartan Tablets (0.15g/Tablet), Under Fasted Condition, Under Fed Condition Trial in Qingdao (Irbesartan Tablet)

Recruiting
  • Irbesartan Tablets (0.15g/Tablet)
  • +3 more
  • Irbesartan Tablet
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Mar 17, 2022

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 850/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 850/50 mg
  • (no location specified)
Apr 16, 2022

Bioavailability Trial in Ruddington Nottingham (Belumosudil Tablet, Belumosudil Capsule)

Completed
Has Results
  • Bioavailability
  • Belumosudil Tablet
  • Belumosudil Capsule
  • Ruddington Nottingham, United Kingdom
    Quotient Clinical Limited
May 9, 2022

Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd.
Nov 10, 2021

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 1000/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 1000/50 mg
  • (no location specified)
Apr 14, 2022

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)

Recruiting
  • Healthy
  • Test Glucophage® XR
  • Reference Glucophage® XR
  • Darmstadt, Germany
    Research Site
Aug 10, 2022